GlobalRPh RX List - XHANCE
- Product / population
- XHANCE intranasal exhalation delivery system; not an inhaled asthma regimen.
- Renal measure
- Renal impairment not formally studied for this device/product.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
Formal pharmacokinetic trials of XHANCE in renal impairment have not been performed. Very low renal clearance described after intravenous fluticasone does not constitute a product-specific severe-CKD or dialysis dosing study. Retain this as an evidence-gap statement, not as an automatic no-adjustment certification.